← All companies
RECURSION PHARMACEUTICALS, INC.
RXRX - CIK 0001601830
Market cap$1.61 B
Rank#2257
SEC filings908
The table below shows RECURSION PHARMACEUTICALS, INC.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $654.47M | $659.84M | $525.11M | $500.45M | $427.65M | $474.34M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.